| Item | Correct answers, n (%) | Knowledge score (%) | ||
| Question 4. How many generations of anti-epileptic drugs are there? |
| 21.2 | ||
|
| 3 generations | 32 (23.4) |
| |
|
| 2 generations | 28 (20.4) |
| |
|
| 1 generation | 26 (19.7) |
| |
| Question 5. What are the conditions for initiating dual therapy? |
| 45.2 | ||
|
| When monotherapy is not sufficiently effective at maximum dose or is poorly tolerated | 80 (58.4) |
| |
|
| In case of failure of two successive monotherapies adapted to the diagnosis of epileptic seizures and at optimal doses | 64 (46.7) |
| |
|
| In case of drug-resistant epilepsy | 42 (30.7) |
| |
| Question 6. What are the conditions for initiating triple therapy? |
| 21.2 | ||
|
| When dual therapy does not completely stop epileptic seizures or is poorly tolerated | 30 (21.9) |
| |
|
| In case of drug-resistant epilepsy | 29 (21.2) |
| |
|
| In case of failure of two successive dual therapies adapted to the diagnosis of epileptic seizures and at optimal doses | 28 (20.4) |
| |
| Question 7. What major or conventional anti-epileptic drugs are commonly used in low-income countries? | 25.5 | |||
|
| Phenobarbital | 53 (38.7) |
| |
|
| Sodium valproate | 46 (33.6) |
| |
|
| Carbamazepine | 30 (21.9) |
| |
|
| Phenytoin | 23(16.8) |
| |
|
| Diazepam | 21 (15.3) |
| |